Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04245085
Title ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma (ABC-lung)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Thoracic Oncology Platform
Indications

lung non-squamous non-small cell carcinoma

Therapies

Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel

Atezolizumab + Bevacizumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries


No variant requirements are available.